---
title: "BUZZ-Organon rises as review finds no issues in past biosimilar purchases"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/276443728.md"
datetime: "2026-02-20T12:57:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276443728.md)
  - [en](https://longbridge.com/en/news/276443728.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276443728.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/276443728.md) | [English](https://longbridge.com/en/news/276443728.md)


# BUZZ-Organon rises as review finds no issues in past biosimilar purchases

Shares of healthcare firm Organon (OGN.N) rise 3.5% to $7.78 premarket

Co says an independent review found no wrongdoing in how it recorded earlier purchases of biosimilars, which are lower-cost versions of complex biologic drugs

Co says its board audit committee launched the review after concerns were raised about timing of past biosimilar purchases; review found no need to revise past SEC filings

Co says the annual report for 2025 will be filed on time

Shares down ~52% in 2025

### 相關股票

- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-HK/quote/IHI.US.md)
- [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-HK/quote/XHE.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [Organon (OGN.US)](https://longbridge.com/zh-HK/quote/OGN.US.md)
- [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-HK/quote/IXJ.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)

## 相關資訊與研究

- [Teva Pharmaceutical Gets US FDA Approval for Prolia Biosimilar; Xoliar Biosimiliar Applications Accepted in US, Europe](https://longbridge.com/zh-HK/news/281026919.md)
- [Teva receives FDA approval for Prolia biosimilar](https://longbridge.com/zh-HK/news/281172040.md)
- [BUZZ-Context Therapeutics rises as FDA grants fast-track status to ovarian cancer drug](https://longbridge.com/zh-HK/news/281517197.md)
- [Io Biotech Inc - Files Voluntary Chapter 7 Bankruptcy Petition On March 31, 2026 - SEC Filing](https://longbridge.com/zh-HK/news/281187506.md)
- [Bourgeon Capital Management LLC Purchases 5,000 Shares of Johnson & Johnson $JNJ](https://longbridge.com/zh-HK/news/281678278.md)